Next |
home / stock / xers / xers message board
Subject | By | Source | When |
---|---|---|---|
Izzy Englander likes $XERS... | price_and_volume | investorshub | 05/27/2022 8:39:29 PM |
Anybody know what this is G85CVR010 ? It-showed-in-my-TD-acct-after | mess124 | investorshub | 01/20/2022 1:17:06 AM |
Yes indeed | Elgordo84 | investorshub | 12/31/2021 4:50:55 PM |
Nice catch in the low 2.00s. | alchemytrader | investorshub | 12/31/2021 1:22:50 PM |
Goodluck to all the Longs! | Elgordo84 | investorshub | 11/15/2021 2:41:48 PM |
Ramping up for sure. | $Money Bags$ | investorshub | 11/15/2021 2:33:41 PM |
I like what I see here! Looks like a | Elgordo84 | investorshub | 11/02/2021 3:01:51 AM |
PDUFA New Years ? | ahimsa27 | investorshub | 10/18/2021 5:10:46 PM |
They stalled the run when they first announced | $Money Bags$ | investorshub | 09/21/2021 12:44:08 PM |
Can we make it rain here? | ezyE | investorshub | 09/16/2021 1:24:25 AM |
Premarket action .. nice news. | kzivann | investorshub | 08/23/2021 12:30:33 PM |
Where is the bottom to$ XERS? I grabbed | tknuncle | investorshub | 08/13/2021 4:29:24 PM |
Item 5. | $Money Bags$ | investorshub | 07/12/2021 8:54:16 PM |
Blackrock sold 2.1m shares into it since their | $Money Bags$ | investorshub | 07/12/2021 8:51:25 PM |
Company on verge of bullish long run consolidated | Modlich | investorshub | 06/30/2021 12:06:43 AM |
Nom nom nom bring the gains. | $Money Bags$ | investorshub | 06/25/2021 6:56:04 PM |
They are acquiring another company, which pushed the | $Money Bags$ | investorshub | 06/04/2021 5:51:23 PM |
Recent announcement of deal caused PT to go | harr449 | investorshub | 06/04/2021 3:50:58 PM |
You guys enjoying the start of this nice run? | $Money Bags$ | investorshub | 06/04/2021 2:33:54 PM |
Delicious. | $Money Bags$ | investorshub | 06/03/2021 5:44:34 PM |
News, Short Squeeze, Breakout and More Instantly...
Xeris Pharmaceuticals Inc. Company Name:
XERS Stock Symbol:
NASDAQ Market:
Xeris Pharmaceuticals Inc. Website:
Xeris Biopharma Holdings, Inc. (Nasdaq: XERS), a growth-oriented biopharmaceutical company committed to improving patients’ lives by developing and commercializing innovative products across a range of therapies, today announced that Paul R. Edick, Xeris’ Chairman and CEO, will pres...
Achieved Total Revenue of over $44M in the fourth quarter – a 34% increase from same period prior year and generated approximately $164M for the full year 2023, a 49% increase versus prior year Ended 2023 with over $72M in cash, cash equivalents, and short-term investments achievin...